CClinicalTrials.gg
TerminatedNCT01345383Updated Mar 10, 2015

Impact of Current Smoking in the Tolerance of Bronchoscopy

An observational study in Smokers, sponsored by Centre Hospitalier Universitaire Saint Pierre. Terminated at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-10.

Sponsored by Centre Hospitalier Universitaire Saint Pierre · Observational

Why this study was terminated
the physician responsable for this protocol left our hospital
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to study the impact of smoking in the preceding hours before a bronchoscopy on the tolerance of this exam.

Read the detailed description

Tolerance evaluation of the bronchoscopy on current and regular smokers. The investigators assess episodes of cough, dyspnea, volume of lidocain (liquid 1% and in spray 10%), duration of the procedure, episodes of desaturation and completion of the bronchoscopy.

The investigators compare patients who did not smoke in the 6 hours before the bronchoscopy and those who have smoked.

02

Conditions studied

  • Smokers

Keywords

  • smoking
  • bronchoscopy
  • cough
03

In context

Lead sponsor

Centre Hospitalier Universitaire Saint Pierre is the lead sponsor of 78 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Current and regular smokers needing a bronchoscopy as determined by their own physician

Inclusion criteria

  • current and regular smoker
  • bronchoscopy under local anesthesia

Exclusion criteria

Exclusion Criteria:

  • patients needing EBUS or fluoroscopy
  • intravenous sedative
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (actual)

Groups and cohorts

  • Current smokers

    Procedure: bronchoscopy

Interventions

  • Procedurebronchoscopy

    Routine bronchoscopy under local anesthesia (lidocain). Duration: +/- 10 min

06

What researchers measure

Primary outcomes

  1. cough

    number of cough episodes during the bronchoscopy

    Time frame: Day 1

Secondary outcomes

  1. dyspnea

    dyspnea evaluation before and during the bronchoscopy

    Time frame: day 1

  2. Lidocaine volume

    Volume of local anesthesic needed during bronchoscopy

    Time frame: day 1

  3. length of bronchoscopy

    length of bronchoscopy

    Time frame: Day 1

  4. desaturation episodes

    desaturation episodes during bronchoscopy

    Time frame: day 1

07

Study locations

1 site
  • CHU Saint Pierre
    Brussels, 1000, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01345383
Lead sponsor
Centre Hospitalier Universitaire Saint Pierre
Responsible party
Marie Bruyneel (Chef de clinique adjoint, Centre Hospitalier Universitaire Saint Pierre) — Principal investigator
First posted
May 2, 2011
Start date
Jun 2010
Primary completion
Aug 2013
Completion
Aug 2013
Last update
Mar 10, 2015

Study contacts

Isabelle De Meulder, MD
principal investigator · Centre Hospitalier Universitaire Saint Pierre

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion